Fluidic Analytics' publication is selected for the ACS Editors' Choice

Congratulations to our resident, Fluidic Analytics, on being selected for the ACS Editors' Choice for their paper

"Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum"!

To view the article on Fluidic Analytics website, click here.

Join us for the Vendors Exhibition at C2I Accelerator: Wed, May 22, 2024; 11 AM-1 PM

CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award

Join us for the Vendors Exhibition at C2I Accelerator: Wed, May 22, 2024; 11 AM-1 PM

C2I Family's 2023 Social Event Memories

We are excited to welcome our new member, Analog Devices!

Welcome to our member, 100X Bioassay!

We are extending a warm welcome to our new member, Fieldstone Bio, Inc.!

C2I Accelerator 2023 Summer Mixer

Bioactivity Supports Premature Infants’ Immunity, Development, and Growth, According to a Review

ODDITY Invests $100M to Bring Revela's AI-Based Molecule Discovery Technology to Beauty and Wellness

Thank you for attending our panel discussion, Strategies to Advance Startups in Today's Environment!

Save the Date: Strategies to Advance Startups in Today's Environment

Business Accelerator | C2I | Life Science | Lease Lab Space | Biotech